Vestmark Advisory Solutions’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $276K | Sell |
1,263
-1,547
| -55% | -$338K | ﹤0.01% | 707 |
|
|
2025
Q1 | $629K | Buy |
2,810
+1,172
| +72% | +$262K | 0.02% | 485 |
|
|
2024
Q4 | $537K | Buy |
1,638
+214
| +15% | +$70.1K | 0.02% | 401 |
|
|
2024
Q3 | $427K | Buy |
1,424
+265
| +23% | +$79.5K | 0.02% | 399 |
|
|
2024
Q2 | $382K | Sell |
1,159
-104
| -8% | -$34.3K | 0.02% | 431 |
|
|
2024
Q1 | $500K | Buy |
1,263
+26
| +2% | +$10.3K | 0.02% | 385 |
|
|
2023
Q4 | $436K | Buy |
1,237
+417
| +51% | +$147K | 0.02% | 361 |
|
|
2023
Q3 | $308K | Sell |
820
-7,692
| -90% | -$2.89M | 0.02% | 342 |
|
|
2023
Q2 | $3.26M | Buy |
8,512
+1
| +0% | +$382 | 0.12% | 213 |
|
|
2023
Q1 | $2.95M | Buy |
8,511
+1,972
| +30% | +$683K | 0.13% | 216 |
|
|
2022
Q4 | $1.54M | Buy |
6,539
+134
| +2% | +$31.5K | 0.08% | 320 |
|
|
2022
Q3 | $1.58M | Buy |
6,405
+424
| +7% | +$104K | 0.09% | 297 |
|
|
2022
Q2 | $1.81M | Buy |
5,981
+243
| +4% | +$73.5K | 0.1% | 258 |
|
|
2022
Q1 | $2.36M | Buy |
5,738
+694
| +14% | +$285K | 0.13% | 206 |
|
|
2021
Q4 | $2.37M | Buy |
5,044
+210
| +4% | +$98.5K | 0.13% | 192 |
|
|
2021
Q3 | $2.05M | Buy |
4,834
+537
| +12% | +$228K | 0.14% | 192 |
|
|
2021
Q2 | $1.54M | Buy |
4,297
+270
| +7% | +$97K | 0.11% | 234 |
|
|
2021
Q1 | $1.14M | Buy |
4,027
+1,074
| +36% | +$303K | 0.1% | 264 |
|
|
2020
Q4 | $837K | Buy |
2,953
+337
| +13% | +$95.5K | 0.09% | 268 |
|
|
2020
Q3 | $719K | Buy |
2,616
+208
| +9% | +$57.2K | 0.1% | 268 |
|
|
2020
Q2 | $547K | Buy |
2,408
+307
| +15% | +$69.7K | 0.08% | 284 |
|
|
2020
Q1 | $320K | Buy |
+2,101
| New | +$320K | 0.06% | 348 |
|
|
2019
Q4 | – | Sell |
-2,126
| Closed | -$302K | – | 526 |
|
|
2019
Q3 | $302K | Sell |
2,126
-12
| -0.6% | -$1.71K | 0.05% | 407 |
|
|
2019
Q2 | $268K | Buy |
2,138
+246
| +13% | +$30.8K | 0.05% | 435 |
|
|
2019
Q1 | $208K | Buy |
+1,892
| New | +$208K | 0.04% | 494 |
|